UVA1 therapy for sclerodermic graft-versus-host disease of the skin [4]

Journal of the American Academy of Dermatology

Volumn 46, Issue 5, 2002, Pages 799-800

  Ständer, Hartmut ^a   Schiller, Meinhard ^a   Schwarz, Thomas ^a  

^a Department of Dermatology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LETTER; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCLERODERMA; ULTRAVIOLET A RADIATION; ULTRAVIOLET IRRADIATION;

EID: 0036587418     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.121352     Document Type: Letter

References (6)

1. Gruss C, Reed JA, Altmeyer P, McNutt NS, Kerscher M. Induction of interstitial collagenase (MMP-1) by UVA1 phototherapy in morphea fibroblasts. Lancet 1997;350:1295-6.
2. Kerscher M, Volkenandt M, Gruss C, Reuther T, von Kobyletzki G, Freitag M. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998;38:21-6.
3. Morita A, Kobayashi K, Isomura I, Tsuji T, Krutmann J, Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. J Am Acad Dermatol 2000;43:670-4.
4. Grundmann-Kollmann M, Behrens S, Gruss C, Gottlober P, Peter RU, Kerscher M. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol 2000;42:134-6.
5. Morita A, Werfel T, Stege H, Ahrens C, Karmann K, Grewe M. Evidence that singlet oxygen-induced human T-helper cell apoptosis is the basic mechanism of ultraviolet-A radiation photo-therapy. J Exp Med 1997;186:1763-8.
6. Stege H, Berneburg M, Humke S, Klammer M, Grewe M, Grether-Beck S. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997;36:938-44.